Literature DB >> 24033566

Hyperforin inhibits cell proliferation and differentiation in mouse embryonic stem cells.

K Nakamura1, K Aizawa, J Yamauchi, A Tanoue.   

Abstract

OBJECTIVES: Hyperforin, a phloroglucinol derivative of St. John's Wort, has been identified as the major molecule responsible for this plant's products anti-depressant effects. It can be expected that exposure to St. John's Wort during pregnancy occurs with some frequency although embryotoxic or teratogenic effects of St. John's Wort and hyperforin have not yet been experimentally examined in detail. In this study, to determine any embryotoxic effects of hyperforin, we have attempted to determine whether hyperforin affects growth and survival processes of employing mouse embryonic stem (mES) cells (representing embryonic tissue) and fibroblasts (representing adult tissues).
MATERIALS AND METHODS: We used a modified embryonic stem cell test, which has been validated as an in vitro developmental toxicity protocol, mES cells, to assess embryotoxic potential of chemicals under investigation.
RESULTS: We have identified that high concentrations of hyperforin inhibited mouse ES cell population growth and induced apoptosis in fibroblasts. Under our cell culture conditions, ES cells mainly differentiated into cardiomyocytes, although various other cell types were also produced. In this condition, hyperforin affected ES cell differentiation into cardiomyocytes in a dose-dependent manner. Analysis of tissue-specific marker expression also revealed that hyperforin at high concentrations partially inhibited ES cell differentiation into mesodermal and endodermal lineages.
CONCLUSIONS: Hyperforin is currently used in the clinic as a safe and effective antidepressant. Our data indicate that at typical dosages it has only a low risk of embryotoxicity; ingestion of large amounts of hyperforin by pregnant women, however, may pose embryotoxic and teratogenic risks.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24033566      PMCID: PMC6495937          DOI: 10.1111/cpr.12060

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  24 in total

Review 1.  Hyperforin: more than an antidepressant bioactive compound?

Authors:  Miguel A Medina; Beatriz Martínez-Poveda; María I Amores-Sánchez; Ana R Quesada
Journal:  Life Sci       Date:  2006-01-24       Impact factor: 5.037

Review 2.  Mitochondria and the autophagy-inflammation-cell death axis in organismal aging.

Authors:  Douglas R Green; Lorenzo Galluzzi; Guido Kroemer
Journal:  Science       Date:  2011-08-26       Impact factor: 47.728

Review 3.  Cytometry in cell necrobiology revisited. Recent advances and new vistas.

Authors:  Donald Wlodkowic; Joanna Skommer; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2010-07       Impact factor: 4.355

4.  Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial.

Authors:  Benedetto Vitiello; Richard I Shader; Corette B Parker; Louise Ritz; William Harlan; David J Greenblatt; Kishore M Gadde; K Ranga R Krishnan; Jonathan R T Davidson
Journal:  J Clin Psychopharmacol       Date:  2005-06       Impact factor: 3.153

Review 5.  Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Authors:  L Ouyang; Z Shi; S Zhao; F-T Wang; T-T Zhou; B Liu; J-K Bao
Journal:  Cell Prolif       Date:  2012-10-03       Impact factor: 6.831

6.  Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells.

Authors:  Christian Liedtke; Jörg Plümpe; Stefan Kubicka; Cynthia A Bradham; Michael P Manns; David A Brenner; Christian Trautwein
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

7.  Evaluating the safety of St. John's Wort in human pregnancy.

Authors:  Myla E Moretti; Ashley Maxson; Fionna Hanna; Gideon Koren
Journal:  Reprod Toxicol       Date:  2009-02-24       Impact factor: 3.143

8.  Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest.

Authors:  M Leist; F Gantner; I Bohlinger; P G Germann; G Tiegs; A Wendel
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

9.  Ready for a comeback of natural products in oncology.

Authors:  Christian Bailly
Journal:  Biochem Pharmacol       Date:  2008-12-31       Impact factor: 5.858

Review 10.  Shaping organisms with apoptosis.

Authors:  M Suzanne; H Steller
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

View more
  2 in total

1.  Advanced in Vitro Safety Assessment of Herbal Medicines for the Treatment of Non-Psychotic Mental Disorders in Pregnancy.

Authors:  Deborah Spiess; Moritz Winker; Alexandra Dolder Behna; Carsten Gründemann; Ana Paula Simões-Wüst
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

2.  Medicinal Plants for the Treatment of Mental Diseases in Pregnancy: An In Vitro Safety Assessment.

Authors:  Deborah Spiess; Moritz Winker; Antoine Chauveau; Vanessa Fabienne Abegg; Olivier Potterat; Matthias Hamburger; Carsten Gründemann; Ana Paula Simões-Wüst
Journal:  Planta Med       Date:  2021-10-08       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.